316
Views
7
CrossRef citations to date
0
Altmetric
Review

Safety of Combination Immune Checkpoint Inhibitors Compared to Monotherapy; A Systematic Review and Meta-Analysis

, & ORCID Icon
Pages 150-157 | Received 17 Dec 2019, Accepted 07 Jan 2020, Published online: 16 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shweta Kamat, Jay Patel, Britny R. Brown & Ami Vyas. (2022) Adverse Events Induced by Nivolumab Plus Ipilimumab vs. Nivolumab Monotherapy among Cancer Patients: A Systematic Review and Meta-Analysis. Cancer Investigation 40:9, pages 777-788.
Read now

Articles from other publishers (6)

Yiru Zhang, Qigu Yao, Yong Pan, Xinru Fang, Haoying Xu, Tingxiao Zhao, Guangqi Zhu, Tianan Jiang, Shibo Li & Hongcui Cao. (2023) Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review. Cancers 15:3, pages 682.
Crossref
Felipe Fanine de Souza, Julia Petry Trevisani, Letícia Caroline Breis, Luís Gustavo Marcelino Sizenando, Marco Antônio Machado Schlindwein, Paola Herreira Silva, Gustavo da Cunha Ribas & Marcus Vinicius Magno Gonçalves. (2022) Central Nervous System Disorders Associated to Immune Checkpoint Inhibitors. Current Cancer Therapy Reviews 18:2, pages 87-94.
Crossref
Lucia Lisi, Pedro Miguel Lacal, Maria Martire, Pierluigi Navarra & Grazia Graziani. (2022) Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment. Pharmacological Research 175, pages 105997.
Crossref
Grazia Graziani, Lucia Lisi, Lucio Tentori & Pierluigi Navarra. 2022. Interaction of Immune and Cancer Cells. Interaction of Immune and Cancer Cells 295 350 .
Jörg Neugebauer, Frank Kistler, Steffen Kistler, Martin Scheer, Günter Dhom & Joachim Zöller. (2021) Minimalinvasive Implantattherapie unter Berücksichtigung der Medikation. ZWR - Das Deutsche Zahnärzteblatt 130:04, pages 143-152.
Crossref
Yuqing Zhu, Hui Cheng, Minhong Zhong, Yijie Hu, Qiushuang Li, Xiangfu Gao & Shan Liu. (2021) The efficacy and safety of combined ipilimumab and nivolumab versus ipilimumab in patients with Stage III/IV unresectable melanoma: A systematic review and meta-analysis. Journal of Cancer Research and Therapeutics 17:7, pages 1679.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.